Summary & Overview
HCPCS A4290: Sacral Nerve Stimulation Test Lead, Each
HCPCS Level II code A4290 designates a sacral nerve stimulation test lead, billed per individual lead. This code captures a discrete durable medical equipment component used during sacral neuromodulation testing for urinary and pelvic floor dysfunctions. Nationally, accurate use of A4290 matters for consistent billing of neuromodulation testing supplies and for aligning facility and DME charges with payer policies.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context for sacral neuromodulation test leads, common billing and service line placement, and payer coverage considerations. The publication summarizes available benchmarks for utilization and reimbursement where provided, highlights relevant policy and coding guidance updates, and clarifies typical site-of-service scenarios for claims processing.
The content is intended for billing managers, compliance officers, and clinicians involved in urology, pelvic floor, and pain management services who need a national perspective on coding, coverage, and administrative considerations for sacral nerve stimulation test leads.
Billing Code Overview
HCPCS Level II code A4290 describes a sacral nerve stimulation test lead, each. This item represents the individual lead component used during sacral neuromodulation testing procedures.
-
Service type: Durable medical equipment component used for neuromodulation testing
-
Typical site of service: Outpatient surgery center or hospital outpatient department, and may also be used in specialized urology or pelvic floor procedure suites
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult with refractory urinary urgency, frequency, or fecal incontinence who has failed conservative therapies (behavioral modification, pelvic floor physical therapy, and medications). The patient is referred to a urologist or colorectal surgeon for evaluation of sacral neuromodulation. After history, physical exam, and appropriate baseline testing (urodynamics, bladder diary, or anorectal physiology as indicated), the clinician performs a percutaneous sacral nerve stimulation test procedure in an outpatient surgical center or hospital ambulatory surgery unit.
The clinical workflow: the patient arrives fasting, consenting and prepped; conscious sedation or monitored anesthesia care is provided as indicated; fluoroscopic guidance is used to place a temporary percutaneous test lead adjacent to the S3 sacral nerve; intraoperative testing confirms appropriate motor and sensory responses; the test lead is secured and externalized to a trial stimulator; the patient completes a trial period (typically 3–7 days to several weeks) to document symptom improvement; if successful, the patient returns for permanent implant (pulse generator and lead placement). The item billed as A4290 is the sacral nerve stimulation test lead supplied and billed per lead used during the trial phase.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | No modifier |